Chitra Saran

418 total citations
10 papers, 200 citations indexed

About

Chitra Saran is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Chitra Saran has authored 10 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pharmacology. Recurrent topics in Chitra Saran's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Hepatitis B Virus Studies (2 papers). Chitra Saran is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Hepatitis B Virus Studies (2 papers). Chitra Saran collaborates with scholars based in United States, Finland and Switzerland. Chitra Saran's co-authors include Kim L. R. Brouwer, Paavo Honkakoski, Henry Ho, Yana Pikman, Gabriela Alexe, Sunkyu Kim, Andrew E. Place, Giovanni Roti, Marian H. Harris and Kimberly Stegmaier and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Chitra Saran

10 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chitra Saran United States 7 107 59 48 40 29 10 200
Akihisa Kaneko Japan 11 63 0.6× 44 0.7× 36 0.8× 17 0.4× 38 1.3× 24 261
Mingqing Chen United States 8 98 0.9× 39 0.7× 10 0.2× 36 0.9× 31 1.1× 13 195
D Surekha India 12 107 1.0× 198 3.4× 61 1.3× 26 0.7× 36 1.2× 22 340
S. Barnett United Kingdom 8 151 1.4× 82 1.4× 34 0.7× 111 2.8× 76 2.6× 19 283
Aurélie Pétain France 8 126 1.2× 100 1.7× 38 0.8× 43 1.1× 41 1.4× 18 320
C. Tyler Kirkland United States 4 108 1.0× 85 1.4× 9 0.2× 34 0.8× 44 1.5× 6 292
Debasis Das Adhikari United States 9 105 1.0× 129 2.2× 20 0.4× 10 0.3× 25 0.9× 19 305
Yusuke Hara Japan 11 78 0.7× 193 3.3× 63 1.3× 61 1.5× 58 2.0× 30 383
Shin‐ichi Tsujimoto Japan 8 26 0.2× 48 0.8× 31 0.6× 22 0.6× 9 0.3× 21 139
Divya Gupta United States 9 88 0.8× 53 0.9× 20 0.4× 15 0.4× 58 2.0× 27 337

Countries citing papers authored by Chitra Saran

Since Specialization
Citations

This map shows the geographic impact of Chitra Saran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chitra Saran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chitra Saran more than expected).

Fields of papers citing papers by Chitra Saran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chitra Saran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chitra Saran. The network helps show where Chitra Saran may publish in the future.

Co-authorship network of co-authors of Chitra Saran

This figure shows the co-authorship network connecting the top 25 collaborators of Chitra Saran. A scholar is included among the top collaborators of Chitra Saran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chitra Saran. Chitra Saran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Saran, Chitra, Henry Ho, Paavo Honkakoski, & Kim L. R. Brouwer. (2023). Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro. Frontiers in Pharmacology. 14. 1147495–1147495. 4 indexed citations
2.
Saran, Chitra & Kim L. R. Brouwer. (2023). Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity. Toxicologic Pathology. 51(7-8). 405–413. 10 indexed citations
3.
Saran, Chitra, Dong Fu, Henry Ho, et al.. (2022). A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity. Scientific Reports. 12(1). 14333–14333. 10 indexed citations
4.
Brouwer, Kim L. R., Raymond Evers, Shuiying Hu, et al.. (2022). Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. Clinical Pharmacology & Therapeutics. 112(3). 461–484. 42 indexed citations
5.
Saran, Chitra, et al.. (2021). Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 380(2). 114–125. 18 indexed citations
6.
Bezençon, Jacqueline, Chitra Saran, James J. Beaudoin, et al.. (2020). Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR−) Rats. Journal of Pharmaceutical Sciences. 110(1). 404–411. 14 indexed citations
7.
Kang, Hee Eun, Melina M. Malinen, Chitra Saran, Paavo Honkakoski, & Kim L. R. Brouwer. (2019). Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions. Drug Metabolism and Disposition. 47(10). 1222–1230. 4 indexed citations
8.
Pikman, Yana, Gabriela Alexe, Giovanni Roti, et al.. (2016). Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 23(4). 1012–1024. 81 indexed citations
9.
Argikar, Upendra A., et al.. (2016). Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways. Drug Metabolism and Disposition. 44(8). 1304–1312. 12 indexed citations
10.
Amaral, Adam, Chitra Saran, Jakal Amin, & Panos Hatsis. (2016). A Comparison of LC-MS/MS and a Fully Integrated Autosampler/Solid-Phase Extraction System for the Analysis of Protein Binding Samples. SLAS DISCOVERY. 21(6). 620–625. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026